In studies where DNA from both tumor tissue and blood was sequenced to rule out the presence of germline mutations, the frequency of somatic BAP1 mutations was considerably higher than that observed in tumors with germline mutations, approaching 50% [23, 27, 34]. The gene discussed is BAP1; the disease is neoplasm.